National

India now 2nd worst-hit Covid nation

India now 2nd worst-hit Covid nation
NEW DELHI, APR 12 | Publish Date: 4/12/2021 12:41:47 PM IST

India has surpassed Brazil to record the second-highest number of COVID-19 cases at 1,35,27,717, as a record 1,68,912 new infections were reported in a day. The active cases have surpassed the 12-lakh mark, while the death toll increased to 1,70,179 with 904 new fatalities in a day, the highest since October 18, 2020, according to the Union Health Ministry data updated at 8 AM on Monday. The national COVID-19 recovery rate has fallen below 90 percent.

According to the Johns Hopkins University (JHU) data, India has overtaken Brazil, which is now at the third spot in the COVID tally with 1,34,82,023 cases.

The US has the highest number of cases at 3,11,98,055 while globally 13,61,36,954 cases have been reported. Registering a steady increase for the 33rd day in a row, the active cases have increased to 12,01,009 in India comprising 8.88 percent of the total infections, while the recovery rate has further dropped to 89.86 percent.

Before the latest surge, the active caseload was at its highest at 10,17,754 on September 18, 2020 and had decreased to 1, 35,926 on February 12. The number of people who have recuperated from the disease surged to 1,21,56,529, while the case fatality rate has further dropped to 1.26 percent, the data stated.

India’s COVID-19 tally had crossed the 60-lakh mark on September 28, 70 lakh on  October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

According to the ICMR, 25,78,06,986 samples have been tested up to April 11 with 11,80,136 samples being tested on Sunday. The health ministry stressed that more than 70 percent of the deaths occurred due to comorbidities. 

“Our figures are being reconciled with the Indian Council of Medical Research,” the ministry said on its website, adding that state-wise distribution of figures is subject to further verification and reconciliation. 

India set to get third vaccine

NEW DELHI, APR 12 (IANS): A government expert panel has given its nod to emergency use authorisation of Russian-made Covid vaccine, Sputnik-V, in India, Union Health Ministry sources said.

After the Drug Controller General of India gives assent to the Subject Expert Committee’s approval, the sources told IANS, India will have a third Covid vaccine after AstraZeneca-Oxford University developed-Serum Institute of India-manufactured Covishield and Bharat Biotech-developed and manufactured Covaxin.

Indian Council of Medical Research’s (ICMR) Dr N.K. Arora, talking to IANS, said: “Though, I am yet to receive any official information about its approval, but it would be good news for India if it is approved.” 

Explaining features of this vaccine, Arora said: “Sputnik is a two dose vaccine. The composition of the first dose will be different from the second dose and there should be at least a three to four weeks gap between the first dose and the second. The published data suggest that it has 91 per cent efficacy. Some more clarity on it will also come soon.”

The development has come at a time when India is witnessing an exponential surge in Covid-19 cases and vaccines have been much in demand.

Launched on December 3,1990. Nagaland Post is the first and highest circulated newspaper of Nagaland state. Nagaland Post is also the first newspaper in Nagaland to be published in multi-colour.

Desk:+91-3862-248 489, e-mail: npdesk@gmail.com Fax: +91-3862-248 500
Advt.:+91-3862-248 267, e-mail:npostadvt@gmail.com

QUICK LINKS

SUNDAY POST

Join us on

© Nagaland Post 2018. All Rights are Reserved
Designed by : 4C Plus